To this regard, the NO/cGMP/PKG/CREB cascade is particularly attractive because drugs boosting it, especially phosphodiesterase 5 (PDE5) inhibitors, are widely used for the therapy of erectile dysfunction and pulmonary hypertension [24], and it is therefore plausible that their administration is compatible with therapeutic usage. The gene discussed is PDE5A; the disease is erectile dysfunction.